FDA Announces Public Meeting of Gastrointestinal Drugs Advisory Committee for Regulatory Advice

Summary

The Food and Drug Administration (FDA) is hosting a public meeting of the Gastrointestinal Drugs Advisory Committee to gather input on regulatory matters, and is seeking public comments on the meeting and its agenda